Merck KGaA (LON: 0O14)

Market Cap	49.78B
Revenue (ttm)	17.44B
Net Income (ttm)	2.24B
Shares Out	n/a
EPS (ttm)	5.15
PE Ratio	22.19
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	27,759
Open	138.05
Previous Close	138.35
Day's Range	136.15 - 138.20
52-Week Range	112.80 - 146.53
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 6, 2025

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing a...

• Industry: Pharmaceutical Preparations
• Founded: 1668
• Employees: 62,908
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0O14

Financial Performance

In 2023, Merck KGaA's revenue was 20.99 billion, a decrease of -5.57% compared to the previous year's 22.23 billion. Earnings were 2.82 billion, a decrease of -15.09%.

Financial numbers in EUR